We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$946M
AUM Growth
+$84.3M
Cap. Flow
+$58.4M
Cap. Flow %
6.17%
Top 10 Hldgs %
5.74%
Holding
1,852
New
717
Increased
240
Reduced
255
Closed
635

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$5.94M
2
BMY icon
Bristol-Myers Squibb
BMY
+$5.81M
3
XEL icon
Xcel Energy
XEL
+$5.01M
4
GIS icon
General Mills
GIS
+$4.97M
5
ABBV icon
AbbVie
ABBV
+$4.95M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$7.75M
2
UPS icon
United Parcel Service
UPS
+$4.82M
3
YUM icon
Yum! Brands
YUM
+$4.38M
4
COP icon
ConocoPhillips
COP
+$3.98M
5
DD icon
DuPont de Nemours
DD
+$3.79M

Sector Composition

Rank Sector Weight
1 Financials 16.69%
2 Consumer Discretionary 14.91%
3 Industrials 14.15%
4 Technology 11.51%
5 Healthcare 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGV icon
1476
iShares Expanded Tech-Software Sector ETF
IGV
$12.2B
-17,375
Closed -$1.06M
IIPR icon
1477
Innovative Industrial Properties
IIPR
$1.78B
-5,998
Closed -$456K
IJJ icon
1478
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.87B
-2,777
Closed -$285K
IJR icon
1479
iShares Core S&P Small-Cap ETF
IJR
$110B
-7,167
Closed -$693K
IJS icon
1480
iShares S&P Small-Cap 600 Value ETF
IJS
$8.14B
-7,114
Closed -$666K
IMO icon
1481
Imperial Oil
IMO
$60.8B
-8,170
Closed -$415K
IMRX icon
1482
Immuneering
IMRX
$282M
-11,114
Closed -$108K
INFA
1483
DELISTED
Informatica
INFA
-25,200
Closed -$413K
INMD icon
1484
InMode
INMD
$884M
-14,241
Closed -$455K
INTU icon
1485
Intuit
INTU
$83.1B
-2,243
Closed -$1,000K
IQ icon
1486
iQIYI
IQ
$1.19B
-32,673
Closed -$238K
IQLT icon
1487
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
-18,875
Closed -$666K
IRM icon
1488
Iron Mountain
IRM
$37.8B
-15,697
Closed -$831K
IRTC icon
1489
iRhythm Holdings
IRTC
$3.69B
-5,261
Closed -$653K
ITOS
1490
DELISTED
iTeos Therapeutics
ITOS
-13,573
Closed -$185K
IVV icon
1491
iShares Core S&P 500 ETF
IVV
$869B
-1,522
Closed -$626K
IWF icon
1492
iShares Russell 1000 Growth ETF
IWF
$120B
-5,144
Closed -$314K
IWN icon
1493
iShares Russell 2000 Value ETF
IWN
$14.4B
-2,062
Closed -$283K
IWY icon
1494
iShares Russell Top 200 Growth ETF
IWY
$15.7B
-4,636
Closed -$644K
IYK icon
1495
iShares US Consumer Staples ETF
IYK
$1.41B
-3,567
Closed -$237K
JAMF
1496
DELISTED
Jamf
JAMF
-21,028
Closed -$408K
JBSS icon
1497
John B. Sanfilippo & Son
JBSS
$978M
-2,328
Closed -$226K
JD icon
1498
JD.com
JD
$41.8B
-12,447
Closed -$546K
JEF icon
1499
Jefferies Financial Group
JEF
$13B
-9,120
Closed -$289K
JJSF icon
1500
J&J Snack Foods
JJSF
$1.46B
-1,565
Closed -$232K

Similar funds

Y-Intercept (HK)'s Q2 2023 Portfolio in Review

As of Q2 2023, Y-Intercept (HK) held 1,852 positions worth $946M, up 9.8% from $861M the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.

Y-Intercept (HK) deployed $58.4M of net new capital in Q2 2023, opening 717 new positions and adding to 240 existing holdings. Its largest new stake was Union Pacific: 29,892 shares worth $6.12M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was ConocoPhillips, an estimated $3.98M trimmed.

  • Y-Intercept (HK)'s largest Q2 2023 buy was Union Pacific: 29,892 shares worth $6.12M.
  • Y-Intercept (HK) added most to Blackstone in Q2 2023, an estimated $4.36M increase.
  • Y-Intercept (HK)'s biggest Q2 2023 reduction was ConocoPhillips, cutting an estimated $3.98M.
  • Y-Intercept (HK) fully exited Cigna in Q2 2023, selling an estimated $7.75M.
  • Y-Intercept (HK)'s ten largest holdings make up 5.7% of its $946M portfolio in Q2 2023.
  • Y-Intercept (HK) opened 717 new positions and closed 635 in Q2 2023.
  • Y-Intercept (HK)'s portfolio value rose 9.8% quarter-over-quarter to $946M.

Based on Y-Intercept (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.